Related Experiment Video
Updated: Aug 29, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan
Akira Sudo1,2, Shiho Honzawa1,3, Ikuya Nonaka2
1Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
Abstract:
The mitochondrial DNA (mtDNA) G13513A mutation in the ND5 subunit gene has been recently reported as a common cause of some phenotypes of mitochondrial myopathy. Until now, the prevalence and characteristics of this mutation in Leigh syndrome (LS) has not been determined. We screened 84 patients with Leigh syndrome (LS) and found the mutation in six (7%) of them. The proportions of mutant mtDNA in muscles were relatively low (42-70%). The onset of symptoms for patients with this mutation was from 9 months to 5 years. It should be noted that five patients had cardiac conduction abnormalities, particularly Wolff-Parkinson-White (WPW) syndrome (three patients). This study suggests that G13513A mutation is a frequent cause of LS and that patients with this mutation may have a characteristic clinical course.
Insights
The G13513A mitochondrial DNA mutation is a frequent cause of Leigh syndrome (LS), occurring in 7% of patients. Patients often exhibit cardiac conduction abnormalities, including Wolff-Parkinson-White syndrome.
Area of Science:
- Genetics
- Mitochondrial Biology
- Neurology
Background:
- The G13513A mutation in mitochondrial DNA (mtDNA) is linked to mitochondrial myopathy.
- Its prevalence and clinical characteristics in Leigh syndrome (LS) remain undetermined.
Purpose of the Study:
- To determine the prevalence of the G13513A mutation in Leigh syndrome patients.
- To characterize the clinical features associated with this mutation in LS.
Main Methods:
- Screening of 84 Leigh syndrome patients for the G13513A mtDNA mutation.
- Analysis of mutant mtDNA proportions in muscle tissue.
- Clinical evaluation of patients, focusing on symptom onset and cardiac abnormalities.
Main Results:
- The G13513A mutation was identified in 6 out of 84 (7%) LS patients.
- Mutant mtDNA proportions in muscles ranged from 42% to 70%.
- Five patients presented with cardiac conduction abnormalities, including three with Wolff-Parkinson-White syndrome.
Conclusions:
- The G13513A mutation is a significant cause of Leigh syndrome.
- Patients with this mutation may exhibit a distinct clinical profile, particularly cardiac involvement.
Related Concept Videos
Animal Mitochondrial Genetics
Sex-linked Disorders
ATP Synthase: Mechanism
Translation
Translation
Mutations
